Rahem Rahmati: Toxic Epidermal Necrolysis in a Pregnant IVF Patient on Hydroxychloroquine
Rahem Rahmati, Executive Secretary at Student Research and Technology Committee, shared a post on LinkedIn about a paper published in Clinical Case Reports:
“A reminder that even established treatments can have rare, severe consequences.
Our latest case report details a pregnant IVF patient who developed life-threatening Toxic Epidermal Necrolysis (TEN) after taking hydroxychloroquine for recurrent implantation failure.
Title: Toxic Epidermal Necrolysis and Recurrent Implantation Failure: Unveiling a Rare Phenomenon During Pregnancy
Authors: Hatav Ghasemi Tehrani, Faezeh Zakerinasab, Negar Khalili Geshnigani, Rahem Rahmati, Nastaran Zamani Dehkordi
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Dec 20, 2025, 10:57Clare Pin-Chia Huang: New Research Links Maternal Diabetes to Pregnancy Risks
-
Dec 20, 2025, 10:53Evaluating Maternal and Neonatal Health in Rheumatoid Arthritis Pregnancies – Hiroki Ozawa
-
Dec 20, 2025, 10:36Enhancing Care for Women Facing Recurrent Pregnancy Loss – SOGC
-
Dec 20, 2025, 05:00Ilana Ferhadian: Celebrating Book Launch
-
Dec 19, 2025, 16:21Launch of National Fertility Plan Marks Public Health Milestone – Collectif BAMP Association
-
Dec 18, 2025, 13:55Insights from Cendrine Siraudin on Fertility Support – Destination Santé
-
Dec 18, 2025, 13:34Alberto Sifuentes Giraldo: Key Insights on Antiphospholipid Syndrome From Recent Study
-
Dec 18, 2025, 13:28New Webinar on Managing Bipolar Disorder in Perinatal Patients – The Periscope Project Perinatal Specialty Consult Psychiatry
-
Dec 18, 2025, 13:16New Score Quantifying Disease Activity in Patients With Antiphospholipid Syndrome – EULAR